XLO Xilio Therapeutics, Inc. - Common Stock
$8.16
价格 · 五月 20, 2026
截至...的财报数据 五月 12, 2026
52周区间
$1–$9
87% of range
分析师评级
STRONG BUY
5 analysts
目标价
$20
+145% upside
P/E (TTM)
-0.2
ROE
-165.5%
净利润率
-80.0%
XLO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$8.15
市值
$3M
P/E (TTM)
-0.2
每股收益 (TTM)
$-4.19
营收 (TTM)
$44M
股息收益率
—
ROE
-165.5%
负债/权益
—
52周区间
$1 – $9
XLO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$44M
2024-12-31
→
2025-12-31
EPS
$-4.19
2020-12-31
→
2025-12-31
自由现金流
$-6M
2021-12-31
→
2025-12-31
利润率
-80.0%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
XLO
同行中位数
P/E (TTM)
-0.2
0.9
P/S (TTM) (市销率 (TTM))
0.1
2.0
P/B (市净率)
0.1
2.3
Price / FCF (股价/自由现金流)
-0.5
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
XLO
同行中位数
Operating Margin (营业利润率)
-95.9%
—
Net Profit Margin (净利润率)
-80.0%
-350.0%
ROA
-31.0%
-69.7%
ROE
-165.5%
-112.4%
ROIC
-119.0%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
XLO
同行中位数
Current Ratio (流动比率)
2.6
2.4
Quick Ratio (速动比率)
2.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
XLO
同行中位数
Revenue YoY (营收同比增长)
589.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
XLO
同行中位数
XLO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
5 位分析师
- 强烈买入 2 40.0%
- 买入 2 40.0%
- 持有 1 20.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-05-15
最低
$20.00
最高
$20.00
中位数目标
$20.00
+145.2%
平均目标
$20.00
+145.2%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.25%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.58 | $-0.59 | 0.01% |
| 2026年3月31日 | $-0.58 | $-0.67 | 0.09% |
| 2025年12月31日 | $0.81 | $-1.70 | 2.5% |
| 2025年9月30日 | $-0.08 | $-0.42 | 0.34% |
| 2025年6月30日 | $-2.24 | $-1.13 | -1.1% |
| 2025年3月31日 | $-2.52 | $1.34 | -3.9% |
| 2024年12月31日 | $-2.80 | $-3.06 | 0.26% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| XLO | $3M | -0.2 | 589.9% | -80.0% | -165.5% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| ESLA | — | -4.5 | — | — | — | — |
| GRML | — | — | — | — | -104.9% | — |
| PSTV | $71M | -1.8 | -10.5% | -429.4% | -636.9% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue | $44M | $6M | |
| R&D Expense | $56M | $41M | |
| SG&A Expense | $30M | $25M | |
| Operating Expenses | $86M | $67M | |
| Operating Income | $-42M | $-61M | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-35M | $-58M | |
| Income Tax | $0 | $0 | |
| Net Income | $-35M | $-58M | |
| EPS (Basic) | $-4.19 | $-15.24 | |
| EPS (Diluted) | $-4.19 | $-15.24 | |
| Shares (Basic) | 8,359,109 | 3,822,244 | |
| EBITDA | $-40M | $-59M |
资产负债表 18
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $138M | $55M | |
| Prepaid Expense | $2M | $5M | |
| Current Assets | $145M | $60M | |
| PP&E (Net) | $4M | $4M | |
| PP&E (Gross) | $13M | $12M | |
| Accum. Depreciation | $9M | $7M | |
| Total Assets | $155M | $71M | |
| Accounts Payable | $3M | $3M | |
| Accrued Liabilities | $12M | $10M | |
| Current Liabilities | $56M | $27M | |
| Capital Leases | $6M | $7M | |
| Total Liabilities | $119M | $53M | |
| Common Stock | $0 | $5.0K | |
| Paid-in Capital | $454M | $401M | |
| Retained Earnings | $-419M | $-384M | |
| Stockholders' Equity | $35M | $18M | |
| Liabilities + Equity | $155M | $71M | |
| Shares Outstanding | 4,530,641 | 3,268,299 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $2M | |
| Stock-based Comp | $7M | $6M | |
| Restructuring | · | $937.0K | |
| Other Non-cash | $22M | $32M | |
| Operating Cash Flow | $-5M | $-18M | |
| CapEx | $518.0K | $36.0K | |
| Investing Cash Flow | $-518.0K | $-36.0K | |
| Financing Cash Flow | $88M | $29M | |
| Net Change in Cash | $82M | $11M | |
| Free Cash Flow | $-6M | $-18M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -95.9% | -955.0% | |
| Net Margin | -80.0% | -918.1% | |
| Pretax Margin | -80.0% | · | |
| EBITDA Margin | -92.4% | -929.0% | |
| ROA | -31.0% | -88.2% | |
| ROE | -165.5% | -302.0% | |
| ROIC | -119.0% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.6 | 2.2 | |
| Quick Ratio | 2.4 | 2.0 |
效率 1
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.4 | 0.1 |
增长率 1
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 589.9% | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $44M | $6M | |
| Net Income TTM | $-35M | $-58M | |
| Market Cap | $3M | $44M | |
| P/E | -0.2 | -0.1 | |
| P/S | 0.1 | 6.9 | |
| P/B | 0.1 | 2.5 | |
| P / Tangible Book | 0.1 | 2.5 | |
| P / Cash Flow | -0.6 | -2.4 | |
| P / FCF | -0.5 | -2.4 | |
| Earnings Yield | -654.7% | -1595.8% |
损益表 11
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $14M | $19M | $8M | $3M | $2M | $2M | $2M | |
| R&D Expense | $20M | $18M | $14M | $15M | $8M | $9M | $11M | $11M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $7M | $6M | $6M | |
| Operating Expenses | $27M | $26M | $21M | $22M | $17M | $15M | $17M | $17M | |
| Operating Income | $-14M | $-12M | $-2M | $-14M | $-14M | $-14M | $-15M | $-15M | |
| Other Non-op | $1M | $921.0K | $1M | $-1M | $586.0K | $536.0K | $742.0K | $779.0K | |
| Net Income | $-10M | $10M | $-16M | $-16M | $-13M | $-13M | $-14M | $-14M | |
| EPS (Basic) | $-0.58 | $-3.74 | $-0.11 | $-0.16 | $-2.49 | $-14.16 | $-0.22 | $-0.24 | |
| EPS (Diluted) | $-0.58 | $-3.74 | $-0.11 | $-0.16 | $-2.49 | $-14.16 | $-0.22 | $-0.24 | |
| Shares (Basic) | 16,347,538 | -306,895,796 | 144,106,869 | 96,447,672 | 5,335,740 | -145,315,581 | 63,465,063 | 57,760,178 | |
| EBITDA | $-14M | · | $-2M | $-14M | $-13M | · | $-15M | $-15M |
资产负债表 19
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $138M | $104M | $122M | $89M | $55M | $61M | $75M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $4M | $5M | $2M | $3M | |
| Current Assets | $154M | $145M | $124M | $124M | $93M | $60M | $63M | $78M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $12M | |
| Accum. Depreciation | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $92.0K | |
| Total Assets | $163M | $155M | $134M | $134M | $104M | $71M | $75M | $90M | |
| Accounts Payable | $1M | $3M | $2M | $4M | $2M | $3M | $972.0K | $1M | |
| Accrued Liabilities | $9M | $12M | $9M | $6M | $4M | $10M | $10M | $10M | |
| Current Liabilities | $43M | $56M | $56M | $53M | $48M | $27M | $38M | $39M | |
| Capital Leases | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | |
| Total Liabilities | $91M | $119M | $142M | $127M | $93M | $53M | $54M | $56M | |
| Common Stock | $1.0K | · | $5.0K | $5.0K | $5.0K | · | $4.0K | $4.0K | |
| Paid-in Capital | $501M | $454M | $421M | $420M | $408M | $401M | $392M | $390M | |
| Retained Earnings | $-428M | $-419M | $-429M | $-413M | $-397M | $-384M | $-371M | $-357M | |
| Stockholders' Equity | $73M | $35M | $-8M | $7M | $11M | $18M | $21M | $33M | |
| Liabilities + Equity | $163M | $155M | $134M | $134M | $104M | $71M | $75M | $90M | |
| Shares Outstanding | 5,782,536 | 4,530,641 | 51,829,013 | 51,827,910 | 51,775,264 | 3,268,299 | 43,958,074 | 43,951,922 |
现金流 10
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $344.0K | $323.0K | $340.0K | $381.0K | $497.0K | $376.0K | $380.0K | $445.0K | |
| Stock-based Comp | $2M | $3M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | $0 | $-41.0K | $30.0K | |
| Other Non-cash | $-15M | · | · | · | $40M | · | · | · | |
| Operating Cash Flow | $-22M | $-2M | $-17M | $-14M | $29M | $-14M | $-14M | $20M | |
| CapEx | $556.0K | $95.0K | $0 | $401.0K | $22.0K | $6.0K | $9.0K | · | |
| Investing Cash Flow | $-556.0K | $-95.0K | $0 | $-401.0K | $-22.0K | $-6.0K | $-9.0K | · | |
| Financing Cash Flow | $36M | $36M | $-285.0K | $47M | $5M | $8M | $-3.0K | $20M | |
| Net Change in Cash | $13M | $34M | $-18M | $32M | $34M | $-6M | $-14M | $40M | |
| Free Cash Flow | $-23M | · | · | · | $29M | · | · | · |
盈利能力 5
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -111.6% | · | -10.1% | -177.7% | -472.7% | · | -652.3% | -623.8% | |
| Net Margin | -75.3% | · | -85.4% | -196.0% | -452.7% | · | -619.5% | -590.8% | |
| EBITDA Margin | -108.9% | · | -10.1% | -177.7% | -455.8% | · | -652.3% | -623.8% | |
| ROA | -7.1% | · | -15.6% | -14.2% | -14.2% | · | -18.4% | -15.3% | |
| ROE | -22.9% | · | -252.9% | -78.3% | -72.8% | · | -38.2% | -27.6% |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 2.2 | 2.3 | 2.0 | · | 1.7 | 2.0 | |
| Quick Ratio | 3.5 | · | 1.8 | 2.3 | 1.9 | · | 1.6 | 1.9 |
效率 1
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.0 | · | 0.0 | 0.0 |
估值 (TTM) 10
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | · | $32M | $16M | · | · | · | · | |
| Net Income TTM | $-55M | · | $-59M | $-57M | $-58M | · | $-62M | $-67M | |
| Market Cap | $49M | · | $44M | $35M | $37M | · | $35M | $42M | |
| P/E | -2.5 | · | -1.3 | -0.8 | -0.6 | · | -0.5 | -0.4 | |
| P/S | 1.1 | · | 1.4 | 2.3 | · | · | · | · | |
| P/B | 0.7 | · | -5.4 | 5.0 | 3.5 | · | 1.7 | 1.2 | |
| P / Tangible Book | 0.7 | · | · | 5.0 | 3.5 | · | 1.7 | 1.2 | |
| P / Cash Flow | -2.2 | · | · | · | 1.3 | · | · | · | |
| P / FCF | -2.1 | · | · | · | 1.3 | · | · | · | |
| Earnings Yield | -39.7% | · | -79.5% | -117.7% | -174.0% | · | -214.5% | -228.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $44M | $6M | — | — | — |
| 营业利润率 % | -95.9% | -955.0% | — | — | — |
| 净收入 | $-35M | $-58M | $-76M | $-88M | $-76M |
| 稀释后每股收益 (EPS) | $-4.19 | $-15.24 | $-2.78 | $-3.22 | $-13.52 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | 0.1 | — | — |
| 流动比率 | 2.6 | 2.2 | 3.0 | — | 15.8 |
| 速动比率 | 2.4 | 2.0 | 2.8 | — | 15.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-6M | $-18M | $-69M | — | $-82M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。